1 Answers

Administer as a 90-minute intravenous infusion followed by LV and 5-FU. A reduction in the starting dose by one dose level may be considered for patients with any of the following conditions: prior pelvic/abdominal radiotherapy, performance status of 2, or increased bilirubin levels.

Refractory colorectal malignancies: 125 mg/m2 once wkly for 4 wk, followed by a 2 wk rest period. 

Metastatic colorectal cancer: As 1st  line treatment: 125 mg/m2 on days 1,8,15 and 22 of a 6-wk cycle.

 

 

ইরিনোটেসিন আইভি ইনফিউশন সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে ইরিনোটেসিন

4897 views